Arcturus Therapeutics Holdings (ARCT) Free Cash Flow (QoQ) (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) Free Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.76% |
| Dec 31, 2025 | 4.27% |
| Sep 30, 2025 | -197.15% |
| Jun 30, 2025 | 83.69% |
| Mar 31, 2025 | -12,320.77% |
| Dec 31, 2024 | 98.81% |
| Sep 30, 2024 | 21.75% |
| Jun 30, 2024 | -425.62% |
| Mar 31, 2024 | -285.44% |
| Dec 31, 2023 | 95.56% |
| Sep 30, 2023 | -167.26% |
| Jun 30, 2023 | 239.91% |
| Mar 31, 2023 | -123.00% |
| Dec 31, 2022 | 450.85% |
| Sep 30, 2022 | -22.36% |
| Jun 30, 2022 | 28.75% |
| Mar 31, 2022 | -27.04% |
| Dec 31, 2021 | -118.59% |
| Sep 30, 2021 | 44.57% |
| Jun 30, 2021 | 23.06% |